- জেনেরিক নাম
- Etoricoxib
- শক্তি
- 120 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- One Pharma Ltd.
Etostar 120 Tablet
Etostar 120 Tablet সম্পর্কে
Etostar 120 Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Etoricoxib এবং শক্তি ১২০ mg। Etostar 120 প্রস্তুত করেছে One Pharma Ltd। Etoricoxib-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Etoricoxib-এর ৯০টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Retoz 90 mg Tablet-এর, প্রতি ইউনিট ৳ ১।
Etostar 120 Tablet কী?
Etostar 120 is a tablet from One Pharma Ltd., with the generic name Etoricoxib. It is also used in some other joint and pain conditions. It works by reducing substances in the body that contribute to pain, inflammation and fever. Ask your doctor or pharmacist if you are unsure about it.
Etostar 120-এর ব্যবহার
It is also for short-term treatment of moderate pain after dental surgery. It reduces pain and inflammation. It is a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and swelling. Ask your doctor whether it is suitable for your condition.
Etostar 120 কীভাবে ব্যবহার করবেন
Take Etostar 120 tablets exactly as your doctor prescribes. Swallow the tablet with water. Etostar 120 is taken by mouth. If you miss a dose or are unsure about anything, ask your doctor or pharmacist. Do not change the dose or stop on your own, and do not take it for longer than advised.
Etostar 120-এর পার্শ্বপ্রতিক্রিয়া
Less common effects include dry mouth, taste changes, mouth ulcers, appetite or weight changes, chest pain, flushing, cough, breathlessness, nosebleeds, anxiety, reduced mental alertness, tingling, electrolyte changes, and muscle or joint pain. Tell your doctor about any side effect that bothers you or does not settle.
সতর্কতা ও নিরাপত্তা
It is not for people with active stomach ulcers or bleeding, severe liver or kidney problems, inflammatory bowel disease, heart failure, or allergy to NSAIDs. Before taking Etostar 120, tell your doctor if you have stomach ulcers or bleeding, heart failure, kidney or liver problems, or inflammatory bowel disease. Older people and those with stomach, heart or kidney risk factors need extra care, so speak to your doctor before starting. The doctor will decide if it is safe for you.
সাধারণ প্রশ্ন
What is Etostar 120 used for?
It is also for short-term treatment of moderate pain after dental surgery. It reduces pain and inflammation.
How is Etostar 120 used?
Take Etostar 120 tablets exactly as your doctor prescribes. Swallow the tablet with water.
What should I watch for while using Etostar 120?
Less common effects include dry mouth, taste changes, mouth ulcers, appetite or weight changes, chest pain, flushing, cough, breathlessness, nosebleeds, anxiety, reduced mental alertness, tingling, electrolyte changes, and muscle or joint pain. Tell your doctor about any side effect that bothers you or does not settle.
Can I use Etostar 120 in pregnancy or while breastfeeding?
It is not for people with active stomach ulcers or bleeding, severe liver or kidney problems, inflammatory bowel disease, heart failure, or allergy to NSAIDs. Before taking Etostar 120, tell your doctor if you have stomach ulcers or bleeding, heart failure, kidney or liver problems, or inflammatory bowel disease.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Etoricoxib is indicated for the symptomatic relief of-- Osteoarthritis (OA)
- Rheumatoid arthritis (RA)
- Ankylosing spondylitis, and
- The pain and signs of inflammation associated with acute gouty arthritis.
- For the short-term treatment of moderate pain associated with dental surgery.
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Etoricoxib is a potent, orally active cyclooxygenase-2 (COX-2) specific inhibitor within, and significantly above, the clinical dose range. Two isoforms of cyclooxygenase have been identified: cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). COX-1 is responsible for prostaglandin-mediated normal physiologic functions such as gastric cytoprotection and platelet aggregation. Inhibition of COX-1 by nonselective NSAIDs has been associated with gastric damage and inhibition of platelet aggregation. COX-2 has been shown to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever. Selective inhibition of COX-2 by etoricoxib (within the clinical dose range) decreases these clinical signs and symptoms with decreased potential for Gl toxicity and effects on platelet aggregation. Etoricoxib produced dose-dependent inhibition of COX-2 without inhibition of COX-1 at doses up to 150 mg daily. Etoricoxib did not inhibit gastric prostaglandin synthesis.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adult and adolescent over 16 years:- Osteoarthritis: The recommended dose is 30 mg once daily. In some patients with insufficient relief from symptoms, an increased dose of 60 mg once daily may increase efficacy.
- Rheumatoid arthritis: The recommended dose is 90 mg once daily.
- Ankylosing spondylitis: The recommended dose is 90 mg once daily.
- Acute gouty arthritis: The recommended dose is 120 mg once daily. In clinical trials for acute gouty arthritis, Etoricoxib was given for 8 days.
- Postoperative dental surgery pain: The recommended dose is 90 mg once daily, limited to a maximum of 3 days.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
With medicine:- Oral anticoagulants: In subjects stabilized on chronic warfarin therapy, the administration of Etoricoxib was associated with an increase in prothrombin time.
- Diuretics, ACE inhibitors and Angiotensin II Antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs.
- Acetylsalicylic Acid: Etoricoxib can be used concomitantly with acetylsalicylic acid at doses used for cardiovascular prophylaxis (low-dose acetylsalicylic acid).
- Ciclosporin and tacrolimus: Although this interaction has not been studied with Etoricoxib, coadministration of ciclosporin or tacrolimus with any NSAID may increase the nephrotoxic effect of ciclosporin or tacrolimus.
- Lithium: NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels.
প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
- Hypersensitivity to the active substance or to any of the excipients.
- Active peptic ulceration or active gastro-intestinai (Gl) bleeding.
- Patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.
- Pregnancy and lactation.
- Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10).
- Estimated renal creatinine clearance <30 ml/min.
- Children and adolescents under 16 years of age.
- Inflammatory bowel disease.
- Congestive heart failure (NYHA ll-IV).
- Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.
- Established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease.
পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Side-effects may include palpitation, fatigue, influenza-like symptoms, ecchymosis; less commonly dry mouth, taste disturbance, mouth ulcer, appetite and weight change, atrial fibrillation, transient ischaemic attack, chest pain, flushing, cough, dyspnoea, epistaxis, anxiety, mental acuity impaired, paraesthesia, electrolyte disturbance, myalgia and arthralgia; very rarely confusion and hallucinations.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The use of Etoricoxib, as with any drug substance known to inhibit COX-2, is not recommended in women attempting to conceive. It is not known whether Etoricoxib is excreted in human milk. Etoricoxib is excreted in the milk of lactating rats. Women who use Etoricoxib must not breastfeed.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
- Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and Gl bleeding.
- Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with Etoricoxib after careful consideration.
- Administration of Etoricoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. Monitoring of renal function in such patients should be considered.
- Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing edema from any other reason.
- Any patients with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormalliver function test has occurred, should be monitored. If signs of hepatic insufficiency occur, or if persistently abnormal liver function tests (three times the upper limit of normal) are detected, Etoricoxib should be discontinued.
- Etoricoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.
- Etoricoxib may mask fever and other signs of inflammation. Caution should be exercised when co-administering Etoricoxib with warfarin or other oral anticoagulants.
মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Administration of single doses of Etoricoxib up to 500 mg and multiple doses up to 150 mg/day for 21 days did not result in significant toxicity. In the event of overdose, it is reasonable to employ the usual supportive measures, e.g., remove unabsorbed material from the Gl tract, employ clinical monitoring, and institute supportive therapy, if required.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store at a temperature of below 30°C, protect from light & moisture. Keep out of reach of children.বিকল্প ব্র্যান্ড: Etoricoxib
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।